Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005602 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas
A Phase 1 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00005602 is a Phase 1 study that has completed, run by Children's Oncology Group. The registered enrollment target is 13 participants.
The verdict
NCT00005602, a Phase 1 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as carboplatin and lobradimil may make the tumor cells more sensitive to radiation therapy. PURPOSE: Phase I trial to study the effectiveness of combining radiation therapy with carboplatin and lobradimil in treating children who have newly diagnosed brain stem gliomas.
Interventions
- DRUG carboplatin
- RADIATION radiation therapy
- DRUG cereport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2001-02 |
| Est. Completion | 2005-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005602
The ClinicalTrials.gov registry entry for NCT00005602 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which carboplatin is the first listed.
NCT00005602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005602 about?
NCT00005602 is a clinical study titled "Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as carboplatin and lobradimil may make the tumor cells more sensitive to radiation therapy. PURPOSE: Phase I trial to study the effectiveness of combining radiation therapy with carboplatin and lobradimil in trea...
What is the current status of trial NCT00005602?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2001-02. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00005602?
The interventions under investigation include: carboplatin (DRUG), radiation therapy (RADIATION), cereport (DRUG).
Who is sponsoring clinical trial NCT00005602?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.